nach oben

Erschienen in:

01.06.2019 | Case report

Anakinra

Disseminated urticarial rash: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

A single-centre retrospective review of 18 patients described one patient [age and sex not stated], who developed allergic reaction in the form of severe disseminated urticarial rash following treatment with anakinra for familial Mediterranean fever [route, dosage, time to reaction onset and outcome not stated]. Consequently, anakinra was changed to canakinumab. …

Kurt T, et al. Efficacy of anti-IL-1 treatment in familial Mediterranean fever: A single-center experience. Pediatric Rheumatology 17 (Suppl. 1): 50 (plus poster) abstr. P1042, 2019. Available from: URL: http://doi.org/10.1186/s12969-019-0313-x [abstract] - Turkey

Titel: Anakinra
Disseminated urticarial rash: case report
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63917-1

Springer Medizin

Anakinra

Disseminated urticarial rash: case report

Excerpt

Weitere Artikel der Ausgabe 1/2019

Domperidone/erythromycin/metoclopramide

Natalizumab

Antineoplastics/bisphosphonates

Methotrexate

Etidronic-acid

Rifampicin/sitafloxacin

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Domperidone/erythromycin/metoclopramide

Natalizumab

Antineoplastics/bisphosphonates

Methotrexate

Etidronic-acid

Rifampicin/sitafloxacin